Crossref
Molecular Docking Study of Primaquine-Favipiravir Based Compounds as Potential Inhibitors of COVID-19 Main Protease
European Reviews of Chemical Research · 05.12.2020 · 7 (1)
DOI: 10.13187/ercr.2020.1.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Reviews of Chemical Research, online erschienen am 05.12.2020. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2020). Molecular Docking Study of Primaquine-Favipiravir Based Compounds as Potential Inhibitors of COVID-19 Main Protease. European Reviews of Chemical Research, 7(1). https://doi.org/10.13187/ercr.2020.1.3
Vancouver
Molecular Docking Study of Primaquine-Favipiravir Based Compounds as Potential Inhibitors of COVID-19 Main Protease. European Reviews of Chemical Research. 2020;7(1). doi:10.13187/ercr.2020.1.3
BibTeX
@article{euvimed2020,
title = {Molecular Docking Study of Primaquine-Favipiravir Based Compounds as Potential Inhibitors of COVID-19 Main Protease},
journal = {European Reviews of Chemical Research},
year = {2020},
volume = {7},
number = {1},
doi = {10.13187/ercr.2020.1.3}
}
EUVIMED